查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000682

治療性呼吸系統市場：按設備類型、應用、最終用戶、分銷管道、技術、模式和患者類型分類－2026-2032年全球市場預測

Therapeutic Respiratory Devices Market by Device Type, Application, End User, Distribution Channel, Technology, Mode, Patient Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，呼吸治療市場價值將達到 246.8 億美元，到 2026 年將成長至 286.1 億美元，到 2032 年將達到 706 億美元，複合年成長率為 16.19%。

主要市場統計數據
基準年 2025 246.8億美元
預計年份：2026年 286.1億美元
預測年份 2032 706億美元
複合年成長率 (%) 16.19%

本報告全面概​​述了不斷發展的治療性呼吸設備趨勢和產品、臨床和商業領導者的策略重點。

本執行摘要對治療性呼吸設備進行了全面分析，檢驗了影響設備研發、分銷和臨床應用的結構性、技術性和監管性因素。其目的是為高階主管、策略團隊和臨床採購相關人員提供清晰、基於證據的關鍵趨勢、競爭動態和營運考量概述，這些因素會影響產品系列和服務線的決策。

對正在重塑呼吸治療設備產品開發和競爭優勢的技術、監管和醫療保健服務變革進行詳細評估。

受人口結構變化、醫療服務模式轉變以及設備技術快速創新等因素驅動，呼吸治療設備的市場環境正經歷變革性變化。人口老化和慢性呼吸系統疾病盛行率上升導致市場需求不斷成長，同時醫療系統也積極從住院治療轉向門診治療和居家管理。因此，產品設計優先考慮便攜性、易用性和與遠端監測功能的整合，以提高治療依從性並減少再入院率。

關稅調整對整個設備價值鏈的採購、生產基地、採購合約和業務永續營運的實際影響。

2025年，美國關稅政策的調整為全球呼吸治療設備供應商和買家帶來了新的商業挑戰和策略考量。關稅的重新調整實際上提高了從海外採購的關鍵零件和成品的進口成本，迫使製造商重新評估其籌資策略和生產地點。進口成本的增加對依賴國內不廣泛生產的專用零件的醫療設備影響尤為顯著，使得供應商多元化和近岸外包策略變得更加重要。

細分市場分析揭示了設備類別、醫療保健環境、分銷管道、技術差異和患者人口統計特徵等方面的差異，這些差異會影響產品的採用。

細分市場分析揭示了不同設備類別和臨床環境下的細微需求模式和技術優先順序差異。根據設備類型，市場可分為吸入器、霧化器、氧氣濃縮機和人工呼吸器。吸入器進一步細分為乾粉吸入器、定量吸入器和緩霧吸入器。霧化器分為噴射式、網式和超音波式，氧氣濃縮機分為攜帶式和固定式，人工呼吸器分為有創式和非侵入式。有創呼吸器進一步細分為壓力控制式和容量控制人工呼吸器。這種詳細的分類突顯了技術上的權衡取捨和不同的人工呼吸器偏好。在居家醫療和醫院環境中，便攜性和噪音水平會影響設備的實施可行性，而在重症監護環境中，先進的通氣模式則更為重要。

對美洲、歐洲、中東和非洲以及亞太市場的採用模式、監管細微差別和商業性方法進行區域評估。

區域趨勢影響著技術採納、監管路徑和商業性實施。在美洲，採購慣例往往優先考慮與臨床結果、成本效益和報銷框架的整合，並且更傾向於選擇能夠顯著減少急診使用、並在門診和居家醫療環境中提供清晰計費路徑的設備。監管政策的協調一致和既定的報銷代碼能夠加速檢驗方案的引進週期，而北美地區的製造能力則可以降低關稅風險並縮短前置作業時間。

我們取得市場領先地位的關鍵促進因素是策略夥伴關係、臨床差異化以及以卓越營運為重點的競爭格局分析。

競爭動態的形成受到成熟醫療設備製造商、靈活敏捷的醫療科技新興企業以及利用軟體和連網型設備功能的新興參與企業之間互動的影響。成熟製造商通常憑藉規模、監管經驗和一體化服務網路競爭，這些優勢有助於其深入滲透醫療管道並獲得長期服務合約。同時，中小企業正透過利基創新、快速的產品改進週期以及有針對性的臨床證據項目來增強自身實力，這些項目能夠展現其在易用性、治療依從性或成本降低方面的差異化優勢。

為製造商和供應商提供可操作的策略藍圖，以最佳化產品設計、供應鏈、臨床證據和通路策略，以實現永續成長。

產業領導企業應優先考慮一系列綜合舉措，以增強韌性、創造臨床價值並加速在所有醫療機構的部署。首先，他們應專注於便攜性、直覺的介面以及與電子健康記錄和遠端監測平台的互通性，並使產品藍圖與以用例主導的設計保持一致。優先進行人體工學測試和真實世界可用性研究將有助於減少部署障礙，並促進與支付方就治療效果進行對話。

我們高度透明的混合方法研究途徑，結合了對主要相關人員的訪談、對監管和臨床文獻的審查以及案例研究，從而得出切實可行的見解。

本研究結合了對臨床負責人、採購專家、醫療設備工程師和法規專家的訪談，以及對近期法規指南、醫療設備核准和公開企業實踐的系統性回顧。研究進行了初步的定性研究，旨在揭示從業人員對醫療設備易用性、臨床績效優先事項以及影響採購決策的因素的觀點。這些訪談構成了一個解釋框架的基礎，該框架適用於各種醫療設備類型、應用領域和最終用戶群體。

結論強調，必須整合產品、證據和營運策略，以因應不斷變化的臨床和政策環境。

總之，呼吸治療設備產業的相關人員正面臨著由技術進步、醫療服務模式轉變以及影響採購的政策變化所驅動的重大變革時期。成功的關鍵在於能否將以人性化的設計、可靠的臨床證據以及靈活的生產和分銷策略相結合。積極應對關稅相關風險、投資於可互通的數位化能力並建立與分段式醫療路徑相契合的商業性模式的機構，將在這個不斷變化的環境中佔據更有利的地位。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 治療性呼吸市場：依設備類型分類

  • 吸入器
    • 乾粉吸入器
    • 定量吸入器
    • 緩霧吸入器
  • 噴霧器
    • 噴射式霧化器
    • 網狀霧化器
    • 超音波霧化器
  • 氧氣濃縮機
    • 攜帶式的
    • 固定式
  • 人工呼吸器
    • 侵入式人工呼吸器
      • 壓力控制人工呼吸器
      • 容量控制人工呼吸器
    • 非侵入性人工呼吸器

第9章 治療性呼吸系統市場：依應用領域分類

  • 門診治療
  • 緊急醫療服務
  • 居家照護
  • 醫院

第10章 治療性呼吸系統市場：依最終使用者分類

  • 門診部
  • 緊急醫療護理
  • 居家照護環境
    • 專業居家照護
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 治療性呼吸系統市場：依分銷管道分類

  • 醫院收購
  • 線上零售
  • 零售藥房
  • 專科診所

第12章 治療性呼吸市場：依技術分類

  • 噴射霧化
  • 網狀霧化
  • 壓力控制輸送
  • 超音波霧化

第13章 治療性呼吸系統市場（按類型分類）

  • 侵入性
  • 非侵入性

第14章 依病患類型分類的治療性呼吸系統市場

  • 成人版
  • 老年人
  • 兒童

第15章 治療性呼吸系統市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 治療性呼吸系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 治療性呼吸系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國呼吸治療市場

第19章 中國呼吸治療市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BNOS Meditech Ltd.
  • Bhagawati Oxygen Ltd.
  • Cramer Decker Medical, Inc.
  • Desco Medical, Inc.
  • Dragerwerk AG & Co. KGaA
  • Ellenbarrie Industrial Gases Ltd.
  • Everest Kanto Cylinder Limited
  • Fisher & Paykel Healthcare Corporation Limited
  • Hamilton Medical AG
  • INOX Air Products Pvt. Ltd.
  • Invacare Corporation
  • Koninklijke Philips NV
  • Luxfer Uttam India Pvt. Ltd.
  • Medtronic plc
  • Nihon Kohden Corporation
  • Nipro Corporation
  • O2 Concepts, LLC
  • Precision Medical, Inc.
  • ProRack Gas Control Products
  • Rama Cylinders Pvt. Ltd.
  • ResMed Inc.
  • Royax Sro
  • SICGIL India Limited
  • Taiyo Nippon Sanso Corporation
  • Vyaire Medical, Inc.
Product Code: MRR-8C74ADFC179A

The Therapeutic Respiratory Devices Market was valued at USD 24.68 billion in 2025 and is projected to grow to USD 28.61 billion in 2026, with a CAGR of 16.19%, reaching USD 70.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 24.68 billion
Estimated Year [2026] USD 28.61 billion
Forecast Year [2032] USD 70.60 billion
CAGR (%) 16.19%

Comprehensive overview framing the evolving therapeutic respiratory device landscape and strategic priorities for product, clinical, and commercial leaders

This executive summary introduces a comprehensive analysis of therapeutic respiratory devices, examining the structural, technological, and regulatory forces reshaping device development, distribution, and clinical adoption. The objective is to provide senior leaders, strategy teams, and clinical procurement stakeholders with a clear, evidence-based synthesis of critical trends, competitive dynamics, and operational considerations that influence decisions across product portfolios and service lines.

We begin by situating therapeutic respiratory devices within the broader continuum of respiratory care, highlighting the increasing convergence of outpatient and home-based treatment models, the acceleration of digital-enabled device features, and the rising emphasis on patient-centric design. Taken together, these forces are elevating the importance of interoperable systems, user-friendly interfaces, and robust post-market surveillance. In this context, leadership must balance the imperatives of clinical efficacy, cost containment, and regulatory compliance while anticipating shifts in payer expectations and care-delivery pathways.

The summary synthesizes cross-cutting evidence from device categories, applications, end users, distribution channels, technologies, modes of delivery, and patient segments to identify actionable priorities. Each section foregrounds implications for product development, commercialization, and supply chain resilience. By focusing on practical insights and recommended actions, this report aims to support informed decisions that strengthen competitive positioning, accelerate time-to-value, and reduce execution risk in a dynamic therapeutic respiratory landscape.

Detailed assessment of the technological, regulatory, and care-delivery transformations reshaping product development and competitive advantage in respiratory devices

The landscape for therapeutic respiratory devices is undergoing transformative shifts driven by demographic trends, care-delivery migration, and rapid innovation in device technologies. Aging populations and rising prevalence of chronic respiratory conditions are increasing demand, while healthcare systems are actively shifting care from inpatient settings to ambulatory care and home-based management. As a result, product design is prioritizing portability, simplicity of use, and integration with remote monitoring capabilities to support adherence and reduce readmissions.

Concurrently, technological advances are changing the performance and usability profile of core device families. Inhalers are evolving with more efficient propellant and powder delivery mechanisms, and nebulizer technologies are moving toward mesh and ultrasonic platforms that offer quieter operation and more consistent aerosol particle sizes. Oxygen concentrators are seeing advances in energy efficiency and compression technology that enable lighter, longer-running portable systems. Ventilator design is integrating smarter algorithms and user interfaces to support both invasive and noninvasive modes across care settings.

Regulatory and reimbursement environments are also shaping innovation trajectories. Regulators are increasingly focused on human factors, cybersecurity, and real-world evidence, while payers emphasize value, outcomes, and the ability to reduce acute care utilization. These forces incentivize manufacturers to invest in clinical validation, interoperable data platforms, and post-market surveillance frameworks. As a consequence, alliances between device makers, software providers, and care network operators are becoming more prominent, reflecting a broader move toward ecosystems that deliver measurable clinical and economic benefits.

Finally, supply chain resilience has risen as a strategic priority. Firms are diversifying supplier bases, regionalizing production footprints, and investing in visibility tools to manage component shortages and logistic disruptions. These operational responses are essential to maintain continuity in product availability and to meet rising demand across multiple care settings. Taken together, the shifts described here are redefining competitive advantage, where success increasingly depends on cross-functional capabilities spanning engineering, regulatory strategy, clinical evidence generation, and commercial partnerships.

Practical implications of tariff adjustments on sourcing, production footprint, procurement contracts, and operational resilience across device value chains

In 2025, adjustments to United States tariff policies introduced a new set of operational headwinds and strategic considerations for global suppliers and purchasers of therapeutic respiratory devices. Tariff realignment has effectively increased landed costs for key components and finished devices sourced internationally, prompting manufacturers to reevaluate sourcing strategies and production footprints. Increased import costs are particularly acute for devices reliant on specialized components not widely manufactured domestically, which has amplified emphasis on supplier diversification and nearshoring initiatives.

These tariff shifts have had a cascading impact on procurement cycles within hospitals, ambulatory care centers, and large homecare service providers. Contract negotiations now factor in greater price volatility and longer lead times as suppliers seek to protect margins or pass incremental costs to buyers. In response, purchasing organizations are increasingly structuring contracts with flexible pricing clauses, volume commitments tied to price protection, and inventory buffering provisions. These contractual changes aim to stabilize supply and cost exposure during periods of trade policy uncertainty.

Manufacturers are responding by accelerating regional manufacturing investments and rationalizing global supply chains to reduce tariff exposure. Such strategic moves include entering joint ventures with local partners, expanding capacity in tariff-favored jurisdictions, and increasing vertical integration for critical components. Additionally, product teams are reviewing bills of materials and exploring component substitutions that preserve clinical performance while lowering tariff-sensitive content. These operational shifts can yield longer product lead times for new introductions as production transitions occur, but they also build resilience against future policy volatility.

From a competitive standpoint, companies that can reconfigure supply chains rapidly and maintain price stability will gain an advantage in tender processes and long-term contracts. Meanwhile, service providers and health systems must weigh the trade-offs between cost, supply security, and the clinical profile of alternative devices when making procurement decisions. Overall, tariff policy adjustments underscore the necessity for an adaptive commercial playbook that aligns sourcing, manufacturing, and contracting strategies to mitigate downstream impacts on availability and total cost of care.

Segment-level analysis revealing device category distinctions, care settings, distribution channels, technology differentials, and patient demographics influencing adoption

Segmentation analysis reveals nuanced demand patterns and technology priorities across device categories and clinical settings. Based on Device Type, the market is studied across Inhalers, Nebulizers, Oxygen Concentrators, and Ventilators, with Inhalers further differentiated into Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler. Nebulizers are examined across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer, while Oxygen Concentrators are categorized as Portable and Stationary and Ventilators as Invasive and Noninvasive, the former subdivided into Pressure Controlled Ventilator and Volume Controlled Ventilator. This granularity highlights where engineering trade-offs and user preferences diverge, with portability and noise profiles influencing uptake in homecare versus hospital settings, and advanced ventilation modes being prioritized in critical care environments.

Based on Application, the market is studied across Ambulatory Care, Emergency Medical Services, Homecare, and Hospital, which clarifies how device design and service models must align with the operational tempo and clinical requirements of each setting. Based on End User, the market is studied across Ambulatory Care Centers, Emergency Services, Homecare Settings, and Hospitals, with Homecare Settings further split into Professional Homecare and Self Administration and Hospitals further divided into Private Hospitals and Public Hospitals. These distinctions matter for training, warranty models, and after-sales support, since devices intended for self-administration emphasize intuitive interfaces and low-maintenance designs, whereas professional settings demand serviceability and integration with clinical records.

Based on Distribution Channel, the market is studied across Hospital Purchase, Online Retail, Retail Pharmacy, and Specialty Clinics, which informs channel strategy and margins. Based on Technology, the market is studied across Jet Nebulization, Mesh Nebulization, Pressure Controlled Delivery, and Ultrasonic Nebulization, highlighting that technology choice affects clinical performance, maintenance burden, and patient experience. Based on Mode, the market is studied across Invasive and Noninvasive delivery options, and based on Patient Type, the market is studied across Adult, Geriatric, and Pediatric populations. Patient demographics and mode of delivery jointly shape device ergonomics, dosing accuracy, and caregiver training programs. Taken together, segmentation underscores where differentiated product features, evidence generation, and channel partnerships will most effectively meet stakeholder needs.

Regional evaluation of adoption patterns, regulatory nuances, and commercial approaches for Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics affect technology adoption, regulatory pathways, and commercial execution. In the Americas, procurement practices tend to emphasize clinical outcomes, cost-effectiveness, and integration with reimbursement frameworks, encouraging devices that demonstrate measurable reductions in acute care utilization and clear pathways for billing in outpatient and homecare settings. Regulatory alignment and established reimbursement codes support faster adoption cycles for validated solutions, while regional manufacturing capacity in North America can mitigate tariff exposure and shorten lead times.

In Europe, Middle East & Africa, diverse regulatory regimes and healthcare financing models create a spectrum of adoption velocities and value thresholds. Western European markets often prioritize clinical evidence and interoperability, while markets across the Middle East and Africa may emphasize price sensitivity and durability under variable infrastructure conditions. Consequently, manufacturers benefit from tailored market entry strategies that adapt device configuration, service offerings, and pricing to local healthcare system capabilities and procurement norms.

In Asia-Pacific, rapid urbanization, expanding private healthcare provision, and growing homecare demand are driving significant uptake of portable and digitally enabled respiratory devices. Regulatory agencies across the region are increasingly harmonizing standards, and local manufacturing ecosystems are expanding, enabling faster commercialization when regulatory and clinical prerequisites are aligned. Across all regions, partnerships with local distributors, adaptation to regional clinical pathways, and investment in regional training and service networks are essential to achieving sustained market traction and to support long-term device performance in varied care environments.

Competitive landscape analysis emphasizing strategic partnerships, clinical differentiation, and operational excellence as primary levers of market leadership

Competitive dynamics are shaped by the interplay of legacy device incumbents, agile medical technology challengers, and new entrants leveraging software and connected-device capabilities. Established manufacturers often compete on scale, regulatory experience, and integrated service networks, which supports deep penetration in institutional channels and long-term service contracts. At the same time, smaller and mid-sized companies are gaining traction through niche innovation, faster product iteration cycles, and targeted clinical evidence programs that demonstrate differentiation on usability, therapy adherence, or cost of care reduction.

Collaboration between device firms and digital health vendors is accelerating, with partnerships focused on remote monitoring, adherence support, and data-driven outcomes measurement. These collaborations create new value propositions for payers and providers by linking device performance to patient outcomes. In parallel, distributors and specialty clinic networks are adapting their portfolios to include a broader range of portable and homecare-focused devices, reshaping route-to-market strategies and after-sales service models.

Mergers, acquisitions, and strategic alliances remain active avenues for capability expansion, enabling parties to combine clinical expertise, regulatory know-how, and geographic reach. Firms that invest in robust clinical programs, human factors engineering, and scalable post-market support differentiate themselves in procurement processes. Operational excellence in manufacturing, quality systems, and supply chain management also contributes materially to competitive positioning, particularly in environments where reliability and uptime are mission-critical for care delivery.

Actionable strategic roadmap for manufacturers and providers to optimize product design, supply chains, clinical evidence, and channel strategies for sustained growth

Industry leaders should prioritize a set of integrated actions to strengthen resilience, capture clinical value, and accelerate adoption across care settings. First, align product roadmaps with use-case driven design by emphasizing portability, intuitive interfaces, and interoperability with electronic health records and remote monitoring platforms. Prioritizing human factors testing and real-world usability studies will reduce adoption friction and support payer conversations about outcomes.

Second, de-risk supply chains by diversifying suppliers, increasing regional manufacturing capacity where feasible, and building inventory strategies that balance cost with continuity. Embedding tariff-sensitivity assessments into sourcing decisions and creating contractual mechanisms for price protection can reduce exposure to trade-policy volatility. Concurrently, streamline bills of materials to minimize reliance on single-source, tariff-exposed components without sacrificing clinical performance.

Third, invest in clinical evidence and health-economic dossiers that demonstrate value across institutional and homecare settings. Clinical partnerships that enable pragmatic studies and post-market evidence collection will enhance reimbursement discussions and procurement evaluations. Fourth, develop channel-specific commercial models that reflect the needs of hospital procurement teams, specialty clinics, retail pharmacy networks, and online retail, ensuring that service and warranty offerings are tailored to how end users will operate the devices.

Finally, pursue strategic collaborations with digital health vendors, payers, and care networks to create bundled solutions that tie device performance to outcomes and cost-of-care improvements. These partnerships can facilitate pilot programs, accelerate payer acceptance, and open pathways to value-based contracting. Taken together, these actions position companies to compete on both clinical merit and commercial relevance.

Transparent mixed-methods research approach combining primary stakeholder interviews, regulatory and clinical literature review, and operational case analysis to support practical insights

This research synthesizes primary interviews with clinical leaders, procurement specialists, device engineers, and regulatory experts, combined with a structured review of recent regulatory guidance, device approvals, and publicly reported company initiatives. Primary qualitative engagements were conducted to surface practitioner perspectives on device usability, clinical performance priorities, and procurement decision drivers. These interviews informed the interpretive framework used across device types, applications, and end-user segments.

Secondary research included a targeted analysis of peer-reviewed clinical literature, regulatory documentation, and patent filings to validate technology trends and to assess the maturity of nebulization, inhalation, oxygen concentration, and ventilation platforms. Operational and supply-chain insights were derived from case studies, manufacturing disclosures, and industry reports, enabling a realistic appraisal of production constraints and sourcing risks. Wherever possible, triangulation was used to corroborate findings across multiple sources and perspectives.

The methodological approach emphasizes transparency in assumptions and a conservative stance on inference when primary or secondary data were limited. Analysis prioritized actionable implications over speculative projections and explicitly linked evidence to recommended actions. Limitations include the evolving nature of trade policy and regional regulatory harmonization, which may change the operational context; the report flags these as areas for ongoing monitoring and rapid reassessment.

Concluding synthesis emphasizing the imperative of integrated product, evidence, and operational strategies to navigate evolving clinical and policy environments

In conclusion, therapeutic respiratory device stakeholders face a period of meaningful change driven by technological evolution, care-delivery migration, and policy shifts that affect sourcing and procurement. Success will depend on the ability to integrate human-centered design, robust clinical evidence, and flexible manufacturing and distribution strategies. Organizations that proactively address tariff-related risks, invest in interoperable digital capabilities, and tailor commercial approaches to segmented care pathways will secure stronger positioning as the landscape evolves.

Decision-makers should treat the insights in this summary as a strategic foundation for targeted investments in product development, evidence generation, and supply chain resilience. By coupling operational discipline with an outcomes-oriented commercial narrative, firms can translate technical advantages into measurable value for providers, payers, and patients. The coming period will reward pragmatic execution that aligns innovation with demonstrable clinical and economic improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Therapeutic Respiratory Devices Market, by Device Type

  • 8.1. Inhalers
    • 8.1.1. Dry Powder Inhaler
    • 8.1.2. Metered Dose Inhaler
    • 8.1.3. Soft Mist Inhaler
  • 8.2. Nebulizers
    • 8.2.1. Jet Nebulizer
    • 8.2.2. Mesh Nebulizer
    • 8.2.3. Ultrasonic Nebulizer
  • 8.3. Oxygen Concentrators
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Ventilators
    • 8.4.1. Invasive Ventilators
      • 8.4.1.1. Pressure Controlled Ventilator
      • 8.4.1.2. Volume Controlled Ventilator
    • 8.4.2. Noninvasive Ventilators

9. Therapeutic Respiratory Devices Market, by Application

  • 9.1. Ambulatory Care
  • 9.2. Emergency Medical Services
  • 9.3. Homecare
  • 9.4. Hospital

10. Therapeutic Respiratory Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Emergency Services
  • 10.3. Homecare Settings
    • 10.3.1. Professional Homecare
    • 10.3.2. Self Administration
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals

11. Therapeutic Respiratory Devices Market, by Distribution Channel

  • 11.1. Hospital Purchase
  • 11.2. Online Retail
  • 11.3. Retail Pharmacy
  • 11.4. Specialty Clinics

12. Therapeutic Respiratory Devices Market, by Technology

  • 12.1. Jet Nebulization
  • 12.2. Mesh Nebulization
  • 12.3. Pressure Controlled Delivery
  • 12.4. Ultrasonic Nebulization

13. Therapeutic Respiratory Devices Market, by Mode

  • 13.1. Invasive
  • 13.2. Noninvasive

14. Therapeutic Respiratory Devices Market, by Patient Type

  • 14.1. Adult
  • 14.2. Geriatric
  • 14.3. Pediatric

15. Therapeutic Respiratory Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Therapeutic Respiratory Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Therapeutic Respiratory Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Therapeutic Respiratory Devices Market

19. China Therapeutic Respiratory Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. B.N.O.S Meditech Ltd.
  • 20.6. Bhagawati Oxygen Ltd.
  • 20.7. Cramer Decker Medical, Inc.
  • 20.8. Desco Medical, Inc.
  • 20.9. Dragerwerk AG & Co. KGaA
  • 20.10. Ellenbarrie Industrial Gases Ltd.
  • 20.11. Everest Kanto Cylinder Limited
  • 20.12. Fisher & Paykel Healthcare Corporation Limited
  • 20.13. Hamilton Medical AG
  • 20.14. INOX Air Products Pvt. Ltd.
  • 20.15. Invacare Corporation
  • 20.16. Koninklijke Philips N.V.
  • 20.17. Luxfer Uttam India Pvt. Ltd.
  • 20.18. Medtronic plc
  • 20.19. Nihon Kohden Corporation
  • 20.20. Nipro Corporation
  • 20.21. O2 Concepts, LLC
  • 20.22. Precision Medical, Inc.
  • 20.23. ProRack Gas Control Products
  • 20.24. Rama Cylinders Pvt. Ltd.
  • 20.25. ResMed Inc.
  • 20.26. Royax S.r.o.
  • 20.27. SICGIL India Limited
  • 20.28. Taiyo Nippon Sanso Corporation
  • 20.29. Vyaire Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
  • TABLE 279. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 282. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 290. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN U